Skip to main content

Merck & Co., Inc. ownership: holders and insider trading

  • MRK · NYSE
  • Pharmaceuticals
  • S&P 500
$143.16−0.90%Close 17 Nov 2026 · Market value $354.8B

As filed, its directors and officers own 0.2% of the shares (proxy statement, 28 Feb 2026); 3,775 institutional managers reported holding 80.2% at 30 Jun 2026. Over the last twelve months, insiders sold $79.29M of shares on the open market, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
VanguardInstitution256M10.37%*Form 13F30 Jun 2026
BlackRock, Inc.Holder227M9.21%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder186M7.53%Schedule 13G31 Mar 2026
State StreetInstitution120M4.88%*Form 13F30 Jun 2026
Wellington ManagementInstitution86.2M3.50%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution60.7M2.46%*Form 13F30 Jun 2026
Charles SchwabInstitution54.4M2.21%*Form 13F30 Jun 2026
Morgan StanleyInstitution48.6M1.97%*Form 13F30 Jun 2026
Fidelity (FMR)Institution45.4M1.84%*Form 13F30 Jun 2026
JPMorgan ChaseInstitution43.9M1.78%*Form 13F30 Jun 2026
Fisher Asset Management, LLCInstitution38.5M1.56%*Form 13F30 Jun 2026
Norges BankInstitution37.0M1.50%*Form 13F30 Jun 2026
UBSInstitution33.3M1.35%*Form 13F30 Jun 2026
Bank of AmericaInstitution30.5M1.24%*Form 13F30 Jun 2026
Northern TrustInstitution26.3M1.07%*Form 13F30 Jun 2026
Goldman SachsInstitution22.1M0.90%*Form 13F30 Jun 2026
Franklin TempletonInstitution19.5M0.79%*Form 13F30 Jun 2026
Legal & GeneralInstitution18.9M0.77%*Form 13F30 Jun 2026
InvescoInstitution18.6M0.75%*Form 13F30 Jun 2026
T. Rowe PriceInstitution18.5M0.75%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth12 Nov 2026Option exercise+58.2K$77.62$4.52M
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth12 Nov 2026Open-market sale−58.2K$148.01$8.61M
Guindo Chirfi · EVP, Access, Policy & Comms13 Aug 2026Open-market sale−10.0K$135.00$1.35M
Zachary Jennifer · EVP, General Counsel12 Aug 2026Option exercise+41.5K$117.89$4.89M
Zachary Jennifer · EVP, General Counsel12 Aug 2026Open-market sale−80.3K$133.46$10.72M
Zachary Jennifer · EVP, General Counsel12 Aug 2026Option exercise+13.4K$84.71$1.14M
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth12 Aug 2026Open-market sale−11.1K$131.61$1.46M
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth12 Aug 2026Open-market sale−600$132.04$79.22K
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth11 Aug 2026Open-market sale−7.4K$131.33$973.2K
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth11 Aug 2026Open-market sale−5.4K$132.35$718.3K
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth10 Aug 2026Open-market sale−20.8K$130.43$2.71M
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth6 Aug 2026Open-market sale−805$131.02$105.5K
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth6 Aug 2026Open-market sale−300$131.02$39.31K
DeLuca Richard R. · EVP&Pres, Merck Animal Heallth6 Aug 2026Open-market sale−4.9K$130.23$644.0K
Guindo Chirfi · EVP, Access, Policy & Comms6 Aug 2026Open-market sale−15.0K$131.00$1.97M
Maraldo David R. · EVP & Pres. MMD5 Aug 2026Option exercise+9.7K$87.10$845.7K
Maraldo David R. · EVP & Pres. MMD5 Aug 2026Open-market sale−9.7K$128.72$1.25M
Maraldo David R. · EVP & Pres. MMD5 Aug 2026Open-market sale−2.7K$128.72$345.7K
Maraldo David R. · EVP & Pres. MMD5 Aug 2026Open-market sale−6.3K$128.72$812.4K
Maraldo David R. · EVP & Pres. MMD5 Aug 2026Option exercise+6.3K$73.73$465.3K
Maraldo David R. · EVP & Pres. MMD5 Aug 2026Option exercise+2.7K$84.71$227.5K
Williams David Michael · EVP,Chief Info&Digital Officer5 Aug 2026Option exercise+34.7K$73.73$2.56M
Williams David Michael · EVP,Chief Info&Digital Officer5 Aug 2026Open-market sale−34.7K$128.77$4.47M
Williams David Michael · EVP,Chief Info&Digital Officer5 Aug 2026Option exercise+13.5K$75.36$1.02M
Williams David Michael · EVP,Chief Info&Digital Officer5 Aug 2026Open-market sale−4.6K$128.77$592.3K

Form 4 filings since 17 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

MRK in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.